News
Latest News & Updates
News Updates
May 1, 2026
LimeRiver Scientists Earn Cover Recognition in the Texas Journal of Microscopy
Read More →Mar 6, 2026
LimeRiver Awarded Three U.S. Patents Protecting Next-Generation True Human™ Antibodies Targeting Interleukin-1 Alpha
Read More →Feb 4, 2026
Advancing Infectious Disease Innovation: New Microscopy Insights from Our UT Austin Collaboration
Read More →Press Releases
Jun 18, 2024
LimeRiver Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer.
Find More →Jan 4, 2024
LimeRiver to Begin Constructing New R&D Facility on its 48-acre Campus.
Find More →Nov 14, 2023
Dr. Alan Kivitz to Chair LimeRiver's Natrunix Program in Rheumatoid Arthritis.
Find More →